Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium amino acid chelate is a dietary mineral supplement consisting of magnesium ions chemically bonded to amino acids, such as glycine or aspartic acid, to form a stable ring structure known as a chelate. This specific chemical form is designed to protect the mineral from reacting with other substances in the digestive tract, thereby enhancing its absorption and bioavailability compared to inorganic magnesium salts like magnesium oxide. It is widely used as a nutritional supplement to support cardiovascular health, muscle function, and nervous system regulation, and to treat or prevent magnesium deficiency (hypomagnesemia). Clinical investigations have explored its potential in managing conditions like asthma, though results have often shown no significant clinical benefit over standard therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium amino acid chelate.